We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Finds Data Manipulation, Other Violations at Apotex’s India Plant
FDA Finds Data Manipulation, Other Violations at Apotex’s India Plant
Canadian generics maker Apotex’s plant in Bangalore, India, has rampant problems with data manipulation, including continuously retesting batches until the desired result is achieved, the FDA charges in a warning letter.